Company Filing History:
1 out of 1 
1 out of 54 
1 out of 721 
Years Active: 2017
Title: Sugawara Akihiro: Innovator in Antibacterial Macrolide Derivatives
Introduction
Sugawara Akihiro is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. With a total of two patents to his name, his work focuses on innovative solutions for treating bacterial infections in animals.
Latest Patents
Sugawara's latest patents include "Tylosin derivatives and method for preparation thereof" and "Antibacterial tylosin derivatives and methods for their preparation." The first patent relates to new macrolide derivatives, specifically new tylosin derivatives, which are designed to treat and prevent bacterial infections in animals. This invention encompasses a pharmaceutical or veterinary composition that includes these derivatives, along with methods for their preparation and use in medicaments. The second patent similarly focuses on new tylosin derivatives and their applications in treating bacterial infections, highlighting the importance of these innovations in veterinary medicine.
Career Highlights
Throughout his career, Sugawara has worked with reputable organizations, including the Kitasako Institute and Bayer Animal Health GmbH. His experience in these institutions has allowed him to refine his expertise in the development of pharmaceutical compositions and methods for combating bacterial infections.
Collaborations
Sugawara has collaborated with notable professionals in his field, including Gerd Kleefeld and Robrecht Froyman. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Sugawara Akihiro's contributions to the field of antibacterial macrolide derivatives demonstrate his commitment to improving animal health through innovative solutions. His patents reflect a significant advancement in veterinary medicine, showcasing the potential for new treatments in combating bacterial infections.